PMID- 36864766 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230411 IS - 2093-2340 (Print) IS - 2092-6448 (Electronic) IS - 1598-8112 (Linking) VI - 55 IP - 1 DP - 2023 Mar TI - Evaluation of the Use of Antimicrobial Therapy for Treating Diabetic Foot Infections in an Indonesia Referral Hospital: A Retrospective Cohort Study. PG - 80-89 LID - 10.3947/ic.2022.0084 [doi] AB - BACKGROUND: Diabetic foot infection (DFI) is a common complication of hyperglycemia and is related to prolongation of hospitalization, mortality, high hospitalization costs and decreased quality of life. Antibiotic therapy is one of the most critical factors in the eradication of infection. This study aims to determine the appropriateness of antibiotic use based on the local and international clinical guidelines and its short-term effect on patients' clinical improvement. MATERIALS AND METHODS: This retrospective cohort study was conducted using secondary data from DFI inpatients from 1 January 2018 to 31 May 2020, from Dr. Cipto Mangunkusumo Hospital (RSCM), the National Referral Hospital of Indonesia. The Gyssens algorithm was used to help assess the appropriateness of antibiotics. All subjects were type 2 Diabetes Mellitus (T2DM) adult patients diagnosed with DFI. The primary outcome was a clinical improvement of infection after 7 - 14 days of antibiotic use. The clinical improvement of infection was defined by a minimum of three of these criteria: reduced or no purulent secretions, no fever, the area around the wound did not feel warm, no or reduced local oedema, no local pain, reduced redness or erythema, and decreased leukocytes count. RESULTS: A total of 113 (63.5%) eligible subjects from a total of 178 were recruited. Among the patients, 51.4% had a duration of T2DM for >/=10 years, 60.2% had uncontrolled hyperglycemia, 94.7% had a history of complications, 22.1% had a history of amputation, and 72.6% had ulcer grade >/=3. Based on the Gyssens algorithm, 54.0% of the subjects were given antibiotics appropriately, while the other 46.0% were not. The proportion of improved patients in the appropriate antibiotics group was higher but not statistically significant than those in the inappropriate group (60.7% vs. 42.3%, P = 0.079). However, the results of the multivariate analysis demonstrated that the appropriate use of antibiotics would increase clinical improvement by 2.6 times, compared to inappropriate use after controlling for the covariates (adjusted odds ratio: 2.616, 95% confidence interval: 1.117 - 6.126, P = 0.027). CONCLUSION: Only half of the patients with DFI received appropriate antibiotics, although an appropriate antibiotics usage was independently associated with better short-term clinical improvement in DFI. This suggests that we should effort to improve appropriateness in antibiotics usage in DFI. CI - Copyright (c) 2023 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS. FAU - Aviatin, Memy AU - Aviatin M AUID- ORCID: 0000-0001-8087-1110 AD - Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia. FAU - Sauriasari, Rani AU - Sauriasari R AUID- ORCID: 0000-0001-7861-4369 AD - Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia. rani@farmasi.ui.ac.id. FAU - Yunir, Em AU - Yunir E AUID- ORCID: 0000-0002-2004-9050 AD - Division of Endocrinology, Department of Internal Medicine Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia. e.yunir@ui.ac.id. FAU - Risni, Hindun Wilda AU - Risni HW AUID- ORCID: 0000-0002-8000-6992 AD - Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia. LA - eng GR - NKB-93/UN2.RST/HKP.05.00/2020/Ministry of Research and Higher Education/Indonesia GR - NKB-2692/UN2.RST/HKP.05.00/2020/Ministry of Research and Higher Education/Indonesia PT - Journal Article DEP - 20230223 PL - Korea (South) TA - Infect Chemother JT - Infection & chemotherapy JID - 101531537 PMC - PMC10079441 OTO - NOTNLM OT - Antibiotics OT - Clinical improvement OT - Diabetic foot OT - Infection COIS- No conflict of interest. EDAT- 2023/03/04 06:00 MHDA- 2023/03/04 06:01 PMCR- 2023/03/01 CRDT- 2023/03/03 02:02 PHST- 2022/06/11 00:00 [received] PHST- 2022/12/26 00:00 [accepted] PHST- 2023/03/04 06:01 [medline] PHST- 2023/03/04 06:00 [pubmed] PHST- 2023/03/03 02:02 [entrez] PHST- 2023/03/01 00:00 [pmc-release] AID - 55.e6 [pii] AID - 10.3947/ic.2022.0084 [doi] PST - ppublish SO - Infect Chemother. 2023 Mar;55(1):80-89. doi: 10.3947/ic.2022.0084. Epub 2023 Feb 23.